ZA200205639B - Pseudopolymorph of (-)-cis-2-(chlorophenyl)-5,7-dihydroxy-8[4R-(3S-hydroxy-1-methyl) piperidinyl]-4H-1-benzopyran-4-one. - Google Patents

Pseudopolymorph of (-)-cis-2-(chlorophenyl)-5,7-dihydroxy-8[4R-(3S-hydroxy-1-methyl) piperidinyl]-4H-1-benzopyran-4-one.

Info

Publication number
ZA200205639B
ZA200205639B ZA200205639A ZA200205639A ZA200205639B ZA 200205639 B ZA200205639 B ZA 200205639B ZA 200205639 A ZA200205639 A ZA 200205639A ZA 200205639 A ZA200205639 A ZA 200205639A ZA 200205639 B ZA200205639 B ZA 200205639B
Authority
ZA
South Africa
Prior art keywords
pseudopolymorph
benzopyran
piperidinyl
chlorophenyl
dihydroxy
Prior art date
Application number
ZA200205639A
Other languages
English (en)
Inventor
Gary L Bafus
Christine M Harrison-Bowman
Gary L Silvey
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of ZA200205639B publication Critical patent/ZA200205639B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Stereophonic System (AREA)
  • Inorganic Insulating Materials (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrane Compounds (AREA)
ZA200205639A 2000-01-18 2002-07-15 Pseudopolymorph of (-)-cis-2-(chlorophenyl)-5,7-dihydroxy-8[4R-(3S-hydroxy-1-methyl) piperidinyl]-4H-1-benzopyran-4-one. ZA200205639B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48471700A 2000-01-18 2000-01-18

Publications (1)

Publication Number Publication Date
ZA200205639B true ZA200205639B (en) 2003-10-15

Family

ID=23925305

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200205639A ZA200205639B (en) 2000-01-18 2002-07-15 Pseudopolymorph of (-)-cis-2-(chlorophenyl)-5,7-dihydroxy-8[4R-(3S-hydroxy-1-methyl) piperidinyl]-4H-1-benzopyran-4-one.

Country Status (26)

Country Link
EP (1) EP1259507B1 (da)
JP (1) JP2003520797A (da)
KR (1) KR100806464B1 (da)
CN (1) CN1174977C (da)
AT (1) ATE273303T1 (da)
AU (1) AU2001226346A1 (da)
BR (1) BR0107726A (da)
CA (1) CA2397593C (da)
CZ (1) CZ301195B6 (da)
DE (1) DE60104822T2 (da)
DK (1) DK1259507T3 (da)
EA (1) EA005247B1 (da)
ES (1) ES2222332T3 (da)
HU (1) HUP0204126A3 (da)
IL (2) IL150638A0 (da)
MX (1) MXPA02007005A (da)
NO (1) NO322572B1 (da)
NZ (1) NZ520280A (da)
PL (1) PL200696B1 (da)
PT (1) PT1259507E (da)
SI (1) SI1259507T1 (da)
SK (1) SK287404B6 (da)
TR (1) TR200402036T4 (da)
TW (1) TWI284129B (da)
WO (1) WO2001053293A1 (da)
ZA (1) ZA200205639B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190175598A1 (en) 2016-08-23 2019-06-13 Eisai R&D Management Co., Ltd. Combination therapies for the treatment of hepatocellular carcinoma
MX2019010981A (es) 2017-03-16 2020-09-07 Eisai R&D Man Co Ltd Terapias de combinacion para el tratamiento de cancer de mama.
AU2019407426A1 (en) 2018-12-21 2021-07-22 Daiichi Sankyo Company, Limited Combination of antibody-drug conjugate and kinase inhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN164232B (da) * 1986-04-11 1989-02-04 Hoechst India
US5284856A (en) * 1988-10-28 1994-02-08 Hoechst Aktiengesellschaft Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives
US5908934A (en) * 1996-09-26 1999-06-01 Bristol-Myers Squibb Company Process for the preparation of chiral ketone intermediates useful for the preparation of flavopiridol and analogs

Also Published As

Publication number Publication date
HUP0204126A2 (hu) 2003-04-28
DK1259507T3 (da) 2004-11-01
DE60104822D1 (de) 2004-09-16
HUP0204126A3 (en) 2006-02-28
AU2001226346A1 (en) 2001-07-31
SI1259507T1 (en) 2005-02-28
WO2001053293A1 (en) 2001-07-26
EA200200775A1 (ru) 2002-12-26
NO20023386L (no) 2002-09-12
NO20023386D0 (no) 2002-07-12
EA005247B1 (ru) 2004-12-30
SK287404B6 (sk) 2010-09-07
SK10362002A3 (sk) 2003-01-09
EP1259507B1 (en) 2004-08-11
JP2003520797A (ja) 2003-07-08
ES2222332T3 (es) 2005-02-01
IL150638A (en) 2009-06-15
IL150638A0 (en) 2003-02-12
MXPA02007005A (es) 2004-09-06
CN1174977C (zh) 2004-11-10
TR200402036T4 (tr) 2004-10-21
CA2397593A1 (en) 2001-07-26
DE60104822T2 (de) 2005-09-01
CZ301195B6 (cs) 2009-12-02
PL356165A1 (en) 2004-06-14
KR100806464B1 (ko) 2008-02-21
ATE273303T1 (de) 2004-08-15
CA2397593C (en) 2009-11-10
KR20020069361A (ko) 2002-08-30
CN1395576A (zh) 2003-02-05
PT1259507E (pt) 2004-12-31
PL200696B1 (pl) 2009-01-30
BR0107726A (pt) 2002-10-01
CZ20022466A3 (cs) 2002-11-13
NO322572B1 (no) 2006-10-30
EP1259507A1 (en) 2002-11-27
NZ520280A (en) 2004-04-30
TWI284129B (en) 2007-07-21

Similar Documents

Publication Publication Date Title
AU6497600A (en) Peracid forming system, peracid forming composition, and methods for making and using
AP2001002225A0 (en) 1-heterocycle substituted diarylamines.
AU2002213336A1 (en) Substituted heterocyclic compounds for treating multidrug resistance
AU2001276048A1 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
AU2001279284A1 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
UA87473C2 (en) Muscarinic acetycholine receptor antagonists
MXPA03005573A (es) Inyector y metodo para la introduccion prolongada de reactivos dentro del plasma.
AU2001280597A1 (en) Compositions for sustained release of analgesic agents, and methods of making and using the same
IL162182A (en) Kits containing oral contraceptives and methods utilizing the same
AU2002241736A1 (en) Method for preventing or treating pain by administering an endothelin antagonist
HUP0400549A3 (en) Novel imidazole derivatives, production method thereof and pharmaceutical compositions containing them
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
AU5749601A (en) Ion-sensitive, water-dispersible polymers composition, a method of making same and items using same
ZA200205639B (en) Pseudopolymorph of (-)-cis-2-(chlorophenyl)-5,7-dihydroxy-8[4R-(3S-hydroxy-1-methyl) piperidinyl]-4H-1-benzopyran-4-one.
AU2002322838A1 (en) Low sensitivity explosive compositions and method for making explosive compositions
HUP0204430A3 (en) Method for the enzymatic resolution of the racemates of aminomethyl-aryl-cyclohexanol derivatives, the obtained new compounds and pharmaceutical compositions containing thereof
AU2002224322A1 (en) Lactam dipeptide and its use in inhibiting beta-amyloid peptiderelease
AU4732001A (en) Thiepino (3,2-b) dihydropyridines and related compositions and methods
PL355992A1 (en) Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one
GB2378135B (en) Compositions derived from modiolus modiolus and methods for making and using same
AU2002223617A1 (en) Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds
EP1351680B8 (fr) Utilisation de l'anethole-dithiolethione dans la prevention et le traitement de la tenotoxicite induite par un medicament
AU2001270741A1 (en) Steel compositions, method for obtaining same and parts made from same
AU2001261116A1 (en) Method and compositions for drug discovery
YU47301A (sh) Diarilamini sa supstituisanim 1-heterociklom